Ken Kuhn

About Ken Kuhn

A results-driven R&D and operations executive leader with 20+ years’ experience developing game-changing technologies at some of the best known, respected, and innovative companies at the forefront of biotechnology. A proven track record of strategic roadmapping and tactical execution to deliver upon business objectives by developing and monetizing new technologies. A successful product development leader with deep expertise in product development process (PDP), critical parameter management (CPM), and 6-sigma blackbelt methodologies. An impactful contributor to companies that have transformed the landscape of next generation sequencing (NGS) and proteomics, resulting in pioneering, massively scalable technologies. A focus on teamwork, innovation and relentless execution, while driving toward scalable architecture solutions. A passionate team builder who assembles high-performance teams to tackle difficult challenges with robust solutions, while maintaining trust, engagement, commitment, accountability and results. Specialties: • Technology Strategy & Evaluation • Fundraising & Budgeting • Building High-Performing Teams • Operations & Cost Reduction • Systems Integration • Robust product development • Program & Project Management • Risk Management • Critical Parameter Management • Six-Sigma Blackbelt • NGS & Proteomics

Experience

1. Vice President, Reagent & Platform Development

   Nautilus Biotechnology

   Aug 2022 — Present

Education

• Drexel University

  Bachelor of Science (B.S.), Biochemistry and Molecular Biology

  1988 — 1993

• Stanford University

  Doctor of Philosophy (Ph.D.), Microbiology and Immunology

  1995 — 2001

• UC San Diego

  Diploma, Executive Perspective for Scientists and Engineers (EPSE), Business Administration and Management

  2008 — 2009